[HTML][HTML] Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh… - Diagnostics (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Methods Forty pediatric (0-12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh… - Diagnostics (2075 …, 2023 - search.ebscohost.com
Abstract Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-
Relapse) and an additional six B-ALL DNA samples (without relapse at 3 years post …
Relapse) and an additional six B-ALL DNA samples (without relapse at 3 years post …
[PDF][PDF] Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh, S Sreedharanunni… - 2023 - researchgate.net
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh, S Sreedharanunni… - …, 2023 - search.proquest.com
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh… - Diagnostics (Basel …, 2023 - europepmc.org
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
[HTML][HTML] Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh, S Sreedharanunni… - Diagnostics, 2023 - ncbi.nlm.nih.gov
Methods: Forty pediatric (0–12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
Therapy-Acquired Clonal Mutations in Thiopurine Drug-Response Genes Drive Majority of Early Relapses in Pediatric B-Cell Precursor Acute Lymphoblastic …
R Thakur, P Bhatia, M Singh… - Diagnostics (Basel …, 2023 - europepmc.org
Methods Forty pediatric (0-12 years) B-ALL DNA samples (20 paired Diagnosis-Relapse)
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …
and an additional six B-ALL DNA samples (without relapse at 3 years post treatment), as the …